Eureka State News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Eureka State News.

Press releases published on September 28, 2026

Sep. 28, 2026

Adhesion Wealth Launches Custom Model Solutions for RIAs

Indeterminate GlobeNewswire

Sep. 28, 2026

NETSOL Technologies reports record fiscal 2026 revenue and full-year profitability, exceeding guidance

Indeterminate GlobeNewswire

Sep. 28, 2026

4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME

Indeterminate GlobeNewswire

Sep. 28, 2026

Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4

Indeterminate GlobeNewswire

Sep. 28, 2026

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212

Indeterminate GlobeNewswire

Sep. 28, 2026

Aemetis Receives $22.4 million from Sale of Section 45Z Clean Fuel Production Tax Credits

Indeterminate GlobeNewswire

Sep. 28, 2026

FRIDAY PNR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit against Pentair plc and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

Indeterminate GlobeNewswire

Sep. 28, 2026

1 WEEK BABA INVESTOR DEADLINE: Alibaba Group Holding Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit before October 5, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces

Indeterminate GlobeNewswire

Sep. 28, 2026

VisionWave Highlights STRATUM Autonomous Ground Systems Platform for Multi-Mission Defense Operations

Indeterminate GlobeNewswire

Sep. 28, 2026

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026

Indeterminate GlobeNewswire

Sep. 28, 2026

NVIDIA Announces a $150 Billion Share Repurchase Authorization Increase

Indeterminate GlobeNewswire

Sep. 28, 2026

Armlogi Holding Corp. Reports Fiscal Year 2026 Financial Results; Warehousing Services Revenue Grows 21.9% to $77.1 Million

Indeterminate GlobeNewswire

Sep. 28, 2026

MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

Indeterminate GlobeNewswire

Sep. 28, 2026

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

Indeterminate GlobeNewswire

Sep. 28, 2026

NVIDIA Launches Open Agent Safety Platform to Secure Agents From Testing to Deployment

Indeterminate GlobeNewswire

Sep. 28, 2026

Frodio Celebrates Its 2nd Anniversary With 1,000 Free Wigs for Its Community

Indeterminate GlobeNewswire

Sep. 28, 2026

National Women’s Health and Fitness Day 2026: Nadula Encourages Women to Move Freely With Comfortable, Secure Hair Solutions

Indeterminate GlobeNewswire